Gong, W., Liu, Y., Seidl, C., Diamandis, E. P., Kiechle, M., Drecoll, E., . . . Dorn, J. (2019). Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer. BMC Cancer.
Citación estilo ChicagoGong, Weiwei, Yueyang Liu, Christof Seidl, Eleftherios P. Diamandis, Marion Kiechle, Enken Drecoll, Matthias Kotzsch, Viktor Magdolen, and Julia Dorn. "Quantitative Assessment and Clinical Relevance of Kallikrein-related Peptidase 5 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." BMC Cancer 2019.
Cita MLAGong, Weiwei, et al. "Quantitative Assessment and Clinical Relevance of Kallikrein-related Peptidase 5 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." BMC Cancer 2019.